Abstract
Background/Aim: Ursolic acid (UA), a triterpene compound present in natural plants, has been shown to induce cytotoxic effects on many human cancer cells through induction of cell-cycle arrest and apoptosis. This study investigated the effects of UA on human lung cancer NCI-H292 cells in vitro. Materials and Methods: Flow cytometric assay was used to measure the percentage of cell viability, apoptotic cell death by double staining of annexin V and propidium iodide (PI), production of reactive oxygen species (ROS) and Ca2+, and mitochondriaI membrane potential (Ψm). UA-induced chromatin condensation and DNA fragmentation were examined by 4’,6-diamidino-2-phenylindole staining and DNA gel electrophoresis, respectively. Western blotting was used to examine the changes of apoptosis-associated protein expression in NCI-H292 cells. Results: UA reduced cell viability and induced apoptotic cell death. UA increased Ca2+ production, reduced Ψm, but did not affect ROS production in NCI-H292 cells. UA increased apoptosis-inducing factor (AIF) and endonuclease G in NCI-H292 cells. Conclusion: Based on these observations, we suggest UA induces apoptotic cell death via AIF and Endo G release through a mitochondria-dependent pathway in NCI-H292 cells.
Lung cancer is the leading cause of cancer-associated death worldwide (1) and divided into non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). The most common type is NSCLC accounting for about 80-85% (2, 3), with poor prognosis and a high incidence of recurrence (4). NSCLC includes adenocarcinoma, squamous cell carcinoma, and large-cell carcinomas (5). Although advanced diagnostics and therapeutics have been developed, the treatment and outcome of lung cancer is still unsatisfactory (4, 6-8).
Characteristics of cancer include uncontrolled cell-cycle progression and deregulation of apoptosis. One of the therapeutic strategies for chemotherapy is to induce cancer cell apoptosis. Apoptosis plays a critical role in the balance between cellular replication and death, in particular for elimination of unwanted, damaged or infected cells (9, 10). Much evidence has shown that chemotherapy drugs in clinical used for patients with cancer via the activation of apoptotic pathways in cancer cells (11-13). When the mitochondria membrane potential (Ψm) decreases, cytochrome c binds to apoptotic peptidase activating factor 1 (APAF1) and caspase-9 to result in a complex which activates caspase-3, leading to cell apoptosis (14), or induces the release of transcription factor from mitochondria for nucleus translocation to develop apoptosis (15, 16).
Natural compounds from plants have been used as anticancer drugs for various cancer types in the clinic (17) such as taxol and vincristine which have been widely used to treat breast, ovary and lung cancer. Ursolic acid (UA), a triterpene compound present in plants (18), such as berries, apples, rosemary and some medicinal plants such as Rosmarinus officinalis, Oldenlandia diffusa, Eriobotrya japonica, and Glechoma hederaceae (19), has antitumor activity in many human cancer cell lines (breast, lung, pancreatic, and prostate cancer) (20, 21). Literature shows that one of the important functions of UA in antitumor activity is to induce cancer cell apoptosis (22-24) and cell-cycle arrest (25, 26). UA derivatives were also shown to be potential therapy candidates in studies on NSCLC cell lines (H460, H322, H460 LKB1t/t) (27).
Although numerous studies have shown that UA induced cell apoptosis and cell-cycle arrest in many human cancer cell lines including NSCLC cell lines, however, none included NSCLC NCI-H292 cells. Therefore, we investigated the effects of UA on the NCI-H292 human lung cancer cells in vitro.
Materials and Methods
Chemicals and reagents. UA, dimethyl sulfoxide (DMSO, as a carrier solvent), propidium iodide (PI), 4’,6-diamidino-2-phenylindole (DAPI), Tris-HCl, trypsin and Annexin V-FITC Apoptosis Detection Kit were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Cell culture medium (RPMI-1640), fetal bovine serum (FBS) and penicillin-streptomycin were purchased from Invitrogen (Carlsbad, CA, USA). Primary antibodies against poly (ADP-ribose) polymerase 1 (PARP), caspase-7, cytochrome c, endonuclease G (EndoG), apoptosis-inducing factor (AIF), B-cell lymphoma 2 (BCL2), BCL2-like 1 (BCL-Xs), BH3 interacting domain death agonist (BID), BH3-only protein BID (tBID), and β-actin, and peroxidase-conjugated secondary antibodies were purchased from Cell Signaling Technology, Inc. (Beverly, MA, USA).
Cell culture. NCI-H292 human lung cancer cell line was obtained from the Food Industry Research and Development Institute (Hsinchu, Taiwan) and was maintained as described previously (28). Cells were grown in 10-cm dishes in RPMI-1640 medium supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 μg/ml) in an atmosphere of 5% CO2 at 37°C (28).
Cell viability assay. NCI-H292 cells were seeded at a density of 1×105 cells/well into 12-well plates (Falcon, Franklin Lakes, NJ, USA) overnight before treatment. Cells were treated with UA at final concentration of 0, 3, 6, 9, 12 and 15 μM for 24 and 48 h. Control cultures were treated with 0.1% DMSO. After incubation, the cells were washed with phosphate-buffered saline (PBS) and stained with PI (5 μg/ml) for measuring cell viability by flow cytometry (Becton-Dickinson, San Jose, CA, USA) as described previously (28).
Apoptotic cell death assay. The procedure was performed based on the guideline provided in Annexin V-FITC Apoptosis Detection Kit. NCI-H292 cells (1×105 cells/well) were incubated with or without 12 μM of UA for 0, 6, 12, 24 and 48 h. All adhering and floating cells were harvested, washed twice with PBS and then transferred into sterile centrifuge tube and stained with annexin-V/PI for analysis of early and late apoptotic cell death by flow cytometry as described previously (28).
DAPI assay. NCI-H292 cells (1×105 cells/well) in 12-well plate were incubated with 0, 3, 6, 9, 12 and 15 μM of UA for 24 and 48 h. At the end of incubation, cells were fixed in 3% paraformaldehyde in PBS for 20 min at room temperature then were washed with PBS and stained with DAPI solution (2 μg/ml). DNA condensation was examined and photographed under a fluorescence microscope as described previously (28). Head intensity was quantified using the CometScore™ Freeware analysis (TriTek Corporation, Sumerduck, VA, USA).
DNA fragmentation assay. The assay for DNA fragmentation was conducted according to the manufacturer's instructions using Suicide Track™ DNA Ladder Isolation Kit (Calbiochem, CA, USA). NCI-H292 cells (5×105 cells/dish) in a 10-cm dish were incubated with 0, 3, 6, 9, and 12 μM of UA for 48 h. DNA was quantitated, analyzed using 1.5% agarose gel electrophoresis, and visualized and photographed under UV illumination as described previously (29).
Measurements of reactive oxygen species (ROS), intracellular Ca2+ and Ψm. Flow cytometric assay was used for measuring the production of ROS and Ca2+ and mitochondrial membrane potential (Ψm). NCI-H292 cells (1×105 cells/well) in 12-well plate were treated with or without UA (12 μM) for 0, 1, 3, 6, 9, 12, 24 and 48 h. Cells were collected and re-suspended in 500 μl of 2’,7’-dichlorodihydrofluorescein diacetate (DCFH2-DA) (10 μM), 500 μl of fluo-3-acetomethoxyester (Fluo-3/AM) (2.5 μg/ml), and 500 μl of 3,3’-dihexyloxacarbo-cyanine iodide (DiOC6) (4 μmol/l) for 30 min and then to measure the changes of ROS (H2O2), intracellular Ca2+, and Ψm, respectively, by flow cytometry as described previously (28, 29). All samples were analyzed in triplicate.
Western blotting analysis. NCI-H292 cells were seeded in 10-cm dish at a density of 5×105 cells/dish and incubated with 12 μM UA for 0, 6, 12, 24 and 48 h. Cells were collected and measured total protein by the Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, USA) with bovine serum albumin as the standard as described previously (28, 29). Proteins were electrophoresed by 10% sodium dodecyl sulfate polyacrylamide gels and transferred onto polyvinylidene fluoride membrane (BioRad, Hercules, CA, USA). The membranes were blocked in 5% nonfat dry milk in 50 mM Tris (pH 7.6), 150 mM NaCl and 0.1% Tween 20 (TBST buffer) for 1 h at room temperature. After washing, the membrane was incubated with primary antibodies against PARP, caspase-7, cytochrome c, Endo G, AIF, BCL2, BCL-Xs, BID, and β-actin at 4°C overnight and washed with TBST. The membranes were incubated with horseradish peroxidase-conjugated anti-rabbit IgG. Immunoreactive proteins as secondary antibody and were visualized and detected by Immobilon™ Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA, USA) (28, 29). The band was quantification using imageJ software (version 1.49o; National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. Results are expressed as the mean±standard deviation from at least three experiments. Statistical differences between UA-treated and control groups were analyzed by one-way ANOVA analysis. Differences with p<0.05 were considered statistically significant.
Results
UA reduced cell viability of NCI-H292 cells. The results indicated that UA at 6, 9, 12 and 15 μM significantly reduced viable NCI-H292 cells in dose-and time-dependent manners (Figure 1A). The half maximal inhibitory concentration (IC50) of UA was 12 μM (Figure 1B).
UA induced apoptotic cell death of NCI-H292 cells. The data indicated that 12 μM of UA induced significant apoptotic cell death only after 24 and 48 h. UA-induced apoptotic cell death of NCI-H292 cells at 48 h treatment was higher than that at 24 h treatment (Figure 2).
UA induced chromatin condensation in NCI-H292 cells. UA-treated NCI-H292 cells were stained with DAPI, visualized and photographed using fluorescence microscopy. The fluorescence intensity of UA-treated NCI-H292 cells was brighter than that of controls in cells after 24 and 48 h treatment, respectively (Figure 3), indicating nicked DNA and chromatin condensation.
UA induced DNA fragmentation in NCI-H292 cells. DNA was isolated from UA-treated cells for DNA gel electrophoresis. As shown in Figure 4, results indicated that UA at 9, 12 and 15 μM clearly induced the DNA ladder (fragmentation), indicating UA induced apoptosis of NCI-H292 cells in vitro.
UA induced intracellular Ca2+ production and reduced the Ψm in NCI-H292 cells. As shown in Figure 5A, 1-12 h treatment did not significantly increase ROS production in NCI-H292. UA increased Ca2+ release with 12, 24 and 48 h treatment, time-dependently (Figure 5B). Ψm was reduced only at 48 h treatment in NCI-H292 cells (Figure 5C).
UA altered expression of apoptosis-associated proteins in NCI-H292 cells. UA increased expression of PARP, caspase-7, cytochrome c, Endo G and AIF (Figure 6A) and BCL-Xs, BID and tBID (Figure 6B) in NCI-H292 cells. UA reduced the expression of BCL2 and BID at 24 h treatment.
Based on these results, UA-induced apoptotic cell death may proceed via mitochondria-dependent pathways in NCI-H292 cells.
Discussion
Numerous studies have shown that UA induced cytotoxic effects and reduced viable cells in many human cancer cell lines via induction of cell apoptosis (20-27) including human lung cancer cells (27), however, no report concerned NCI-H292 cells in vitro. Thus, in the present experiments, we investigated the effects of UA on NCI-H292 human lung cancer cells in vitro. NCI-H292 cells were treated with different concentrations of UA for 24 and 48 h and results indicated that UA reduced total viable cell dose-dependently (Figure 1). This finding is in agreement with other reports showing that UA reduced total viable cells in other NSCLC cell lines (H460, H322, H460 LKB1t/t) (27).
It is well documented that many chemotherapeutic drugs exert their antitumor functions via the induction of cell apoptosis in many human cancer cell types. Therefore, in order to further investigate whether UA reduced total viable cells through the induction of apoptotic cell death or not, annexin V/PI double staining was used for examining apoptotic cell death in NCI-H292 cells in vitro. Herein, the results indicated that UA at 12 μM induced 18-58% of apoptotic cell deaths on 24 and 48 h treatment of NCI-H292 cells, respectively (Figure 2A and B). Annexin V/PI double staining is generally used to evaluate cell apoptosis. Apoptosis may develop as a defense mechanism after cells are damaged by noxious agents (10).
DAN damage including DNA condensation and DNA fragmentation is a characteristic of cell apoptosis. DNA damage was found using DAPI staining for examining DNA condensation and DNA gel electrophoresis for examining DNA fragmentation (DNA ladder) (cell apoptosis) (30); furthermore, internucleosomal fragmentation of nuclear DNA is a hallmark of apoptosis (31, 32). Staining of cells with DAPI did not lead to ultrastructural changes compared to those not stained with DAPI (33, 34). DAPI is a nucleic-acid specific fluorophore that is widely used in chromosome staining (35). DAPI fluorescence can be used for investigating chromatin condensation in human chromosomes (34). Our results indicated that UA induced DNA condensation and fragmentation (ladder) and resulted in the induction of apoptotic cell death in NCI-H292 cells. Much evidence has shown that irradiation or drugs used for cancer chemotherapy lead to DNA damage followed by apoptotic death through a p53-dependent pathway (36, 37).
Herein, results indicated that UA increased the levels of Ca2+ with 12-48 h treatment, and reduced Ψm at 48 h, however, it did not significantly affect the production of ROS by NCI-H292 cells. Literature reports that the production of ROS is involved in apoptotic cell death (38). However, we suggest that UA-induced cell apoptosis is independent of ROS pathways. Ca2+ uptake into the mitochondrial matrix was shown to be involved with cellular function (39). Our results indicated that UA-induced apoptotic cell death may involve a mitochondria-dependent pathway.
For further confirmation, western blotting assay was performed and showed that UA increased the expression of PARP, caspase 7, cytochrome c, AIF and Endo G in NCI-H292 cells. The formation of FAS/FASL signaling complex which may trigger the activation of caspase-8 for inducing cells apoptosis via the activation of caspase-3, -6, or -7 and then either directly (extrinsic pathway) or indirectly (intrinsic pathway) via the mitochondrial apoptotic signal pathway is well documented (40). BID, involved in the intrinsic signaling pathway, is cleaved by caspase-8 to form the activated form tBID which is translocated to the mitochondria and disrupts organelles (41-43). Furthermore, the intrinsic signaling pathway involves dysfunction of mitochondria and leads to the release of cytochrome c followed by activation of caspase-3, which results cell apoptosis (14) or directly releases apoptogenic molecules from mitochondria such as AIF and Endo G to induce apoptosis (44, 45). Other reports also showed that UA inhibited cell growth and induced apoptosis via the modulation of the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway in human prostate cancer cells (46).
Based on these observations, the possible molecular mechanism of UA-induced apoptotic cell death may involve the release of apoptogenic molecules, in particular both AIF and Endo G, from mitochondria in NCI-H292 cells. Further studies should be performed to confirm these observations in vivo.
Acknowledgements
This work was supported by grant 105-31 from Cheng-Hsin General hospital, Taipei Taiwan. Experiments and data analysis were performed in part through the use of the Medical Research Core Facilities Center, Office of Research & Development at China Medical University, Taichung, Taiwan.
Footnotes
This article is freely accessible online.
Conflicts of Interest
The Authors do not have any conflicts of interest to disclose in regard to this study.
- Received November 19, 2018.
- Revision received December 10, 2018.
- Accepted December 12, 2018.
- Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved